Formalizing
cannabinoid
based
medicine

Formalizing
cannabinoid
based
medicine

Praesidio Health

An industry-leading, Canadian medical research company that develops and validates cannabinoid-based medicine using an evidence-based process.

Cannabinoid-based medicine DEVELOPMENT

Praesido Health blends leading natural health products with LP supplied cannibinoid using a certified lab. This unique formulation is used to test effects in patients according to evidence-based guidelines.

Additionally, we're branching out to conduct medical research of CBM use in chronic visceral pain conditions (including Irritable Bowel Syndrome and Interstitial Cystitis), anxiety, cardiovascular disorders and menopausal symptom relief.

Praesidio Health benefits from an exclusive partnership with Exdeo Clinical Research Inc., which has prominent expertise in study design, patent organization, and federal regulatory compliance, and has completed more than 24 large-scale Urology clinical trials.

Pioneering CBMs and therapeutics, Praesidio Health is actively developing several CBMs for utility in a range of urological conditions. We're also arranging evidence-based research on select CBMs showing clinical efficacy in proof of concept studies. It's timely, considering urological conditions affect approximately 40% of men over 50, and the aging male population in North America is driving sales of BPH drugs to projected revenues of 5 billion dollars (USD) by 2021.

Praesidio:  to protect (Latin)

We originally started as a group of physicians in 2016 with a common goal: To become a medical chaperone to patients requiring medicinal cannabinoid.

Over the past decade, while the demand for medicinal cannabinoid has been rapidly increasing, we realized there was very limited and inaccurate information available to our patients.

Wanting to improve our patients' health and keep them safe, we formed Praesidio Health. By developing evidence-based clinical standards and guidelines, we help prescribing physicians optimize their patients’ treatment and safety.

 

Cannabinoid-based Medicine Research

Cinical Trials

As an integrated clinical trial organization (CTO), Praesidio Health evaluates CBMs and therapeutics for safety and efficacy. All of our trials are ethically approved, follow good clinical practice (ICH-GCP) guidelines, and adhere to Health Canada and FDA regulations.

Comprehensive Clinical Process

We advance CBM development through systematic clinical trial management. Our medical specialists, statisticians and authorities can design a clinical study for you. We can also conduct and manage a protocolled CBM clinical trial, testing your proprietary CBM in a scientific, evidence-based evaluation.

Cinical Trial Design

Praesidio Health's in-house medical research team offers clinical trial consulting services to organizations with CBMs in development. We can also develop custom trial designs to test other CBMs in specific medical conditions.

Clinical Trial Management

Our research specialists provide clinical trial management services to organizations with CBMs in development. We cover all aspects of clinical trials, including global site evaluation, selection and monitoring. Additionally, our team optimizes patient accrual and streamlines study logistics, including regulatory and credentialing processes for individual research sites. This expedites study completion and publication of clinical trial results.

Revenue

Clinical trial design and management services are negotiated individually on a contract basis.

Chief Medical Officer
Dr. George Vrabec MD FRCSC (Urol.)

As a Urologist, Surgeon and Principal Investigator of Exdeo Clinical Research, Dr. Vrabec has conducted more than 30 clinical trials in a wide array of Urological diseases, and has published in various journals, including the New England Journal of Medicine. Known for optimizing operating procedures and bringing creativity to science, he serves on multiple boards, including Fraser Valley Health Care Foundation.

 

Clinical Research Director
Samuel Tan BSC

As Clinical Research Director, Samuel leverages almost a decade of experience in clinical research project management and site monitoring, along with therapeutic experience in cardiovascular, oncology, auto-immune and osteoporosis. He also maintains extensive knowledge of ICH-GCP, Health Canada and FDA regulations.

 

Chief Operations Officer
Keith Peterson

As Chief Operations Officer, Keith utilizes his decade of experience working with small to global organizations in achieving revenue goals, accomplished by process improvement, business development, and expansion of strategic partnerships.    A conceptual and analytical thinker; able to interpret, and synthesize complex business issues and strategies.  Keith is passionate about marketing and sales with deep expertise in regulatory compliance, commercialization buildout, and product launch.

 

In the media